1. Tell us briefly about IQVIA’s history, mission, and values

IQVIA is a global leader in the use of data, technology, advanced analytics, and scientific expertise to help healthcare clients improve patient outcomes. We combine data science with deep industry knowledge to accelerate medical innovation and enhance health results through an innovative approach powered by artificial intelligence and predictive analytics. This enables organizations around the world to optimize clinical research, improve access to treatments, and transform healthcare delivery.

2. Tell us about your professional background and your current role at IQVIA

My career path perfectly reflects what IQVIA stands for — a company that believes in internal growth, opportunity creation, and a long-term vision. I joined IQVIA 17 years ago, spending my first 13 years in the business consulting area focused on pharmaceutical laboratories. I later led the Consumer Health business unit for three years, and since January 2025, I have had the honor of serving as General Manager of IQVIA Spain.

3. What is the element that most differentiates your organization, or of which you are most proud?

First, IQVIA is a company that works exclusively within the healthcare sector, which gives us a very high level of specialization. Second, IQVIA holds world-class real-world information assets — from drug development to the outcomes of healthcare interventions — allowing us to rebuild the entire knowledge chain of the healthcare ecosystem from start to finish. We do this by combining people and capabilities from different teams across the company, from accelerating diagnosis to improving therapies and evaluating their results. Many companies cover some of these aspects, but none can do so quite like IQVIA — and certainly not at a global scale.

4. Why are Spain and the United States important for your company?

Spain is a crucial market for IQVIA as a global company, as it is a powerhouse in clinical development for multiple reasons. Today, it ranks second worldwide in clinical trial activity, just behind the United States. In the past year alone, nearly 180,000 Spaniards participated in clinical trials, the vast majority of them led or supervised by IQVIA’s Clinical division. We also have a workforce of around 1,800 employees, most of whom are based in our Madrid and Barcelona offices. Thanks to Spain’s strong talent pool, language skills, and capabilities, it also serves as the hub for several global operations supporting teams around the world in areas such as Consulting, Technology, Finance, and Human Resources. The United States, on the other hand, is our headquarters country. Our corporate headquarters in North Carolina houses IQVIA’s global strategic functions, including executive leadership, Finance, Human Resources, R&D, and Technology, as well as the IQVIA Institute for Human Data Science, which provides key insights into the global healthcare ecosystem and directly informs strategic decisions across Europe.

5. Why did you choose to become a member of AmChamSpain?

At IQVIA, one of our core purposes is to continue serving as a connector among key stakeholders in the healthcare ecosystem — including the pharmaceutical industry, medical researchers, government agencies, payers, non-profit organizations, and others involved in patient care. Collaboration among all of these actors is essential to strengthening this ecosystem, and being part of such a solid and well-established forum as AmChamSpain, with its strong network of members and deep transatlantic focus, allows us to better understand U.S. business strategies and market trends while fostering dialogue and cooperation across both countries.